The Multistage Concept of Carcinogenesis

作者: Carl Peraino , Carol A. Jones

DOI: 10.1007/978-1-4684-5523-6_7

关键词: CarcinogenCancer researchCocarcinogenesisNeoplastic transformationTumor promotionBiologyPopulationCellCarcinogenesisCocarcinogen

摘要: The recognition of carcinogenesis as a complex multievent process has developed from evidence gained over the past 50 years research in experimental oncology demonstrating that tumors can be induced high yield by combined administration agents may have little or no carcinogenic activity when given singly. Three major types tumorigenic enhancement defined on basis inducing used and temporal relationships their administration: 1. Syncarcinogenesis: Synergistic tumor formation simultaneous1 sequential treatment2 with two carcinogens separately relatively activity 2. Cocarcinogenesis: Enhancement simultaneous carcinogen an additional agent (cocarcinogen) intrinsic but facilitates action3–8 3. Two-stage, initiation-promotion carcinogenesis: (initiator) (promoter) expression prior carcinogen-induced cryptic cellular changes.3 In this context, initiating is exemplified subcarcinogenic dose carcinogen, i.e., one will not elicit neoplasms within life span animal produce irreversible fundamental change (i.e., mutation) cells target organ tissue so to predispose them neoplastic transformation they are further subjected appropriate promoting stimulus. A promoter, certain plant products, hormones, xenobiotics acts affect gene stimulate hyperplastic expansion initiated cell population. This ultimately results development persistent precancerous nodules, papillomas, polyps organ. Some these lesions then undergo progression malignant (see Chapter 10).

参考文章(132)
Molly F. Kulesz-Martin, Barbara Koehler, Henry Hennings, Stuart H. Yuspa, Quantitative assay for carcinogen altered differentiation in mouse epidermal cells Carcinogenesis. ,vol. 1, pp. 995- 1006 ,(1980) , 10.1093/CARCIN/1.12.995
C. LASNE, A. GENTIL, I. CHOUROULINKOV, Two-stage Malignant Transformation of Rat Fibroblasts in Tissue Culture Nature. ,vol. 247, pp. 490- 491 ,(1974) , 10.1038/247490A0
G. J. Hopkins, G. C. Hard, C. E. West, Carcinogenesis Induced by 7,12-Dimethylbenz[a]anthracene in C3H-A vyfB Mice: Influence of Different Dietary Fats JNCI: Journal of the National Cancer Institute. ,vol. 60, pp. 849- 853 ,(1978) , 10.1093/JNCI/60.4.849
Helen W. Lane, Janet S. Butel, Cindy Howard, Frances Shepherd, Rekha Halligan, Daniel Medina, The role of high levels of dietary fat in 7,12-dimethyl-benzanthracene-induced mouse mammary tumorigenesis: lack of an effect on lipid peroxidation Carcinogenesis. ,vol. 6, pp. 403- 407 ,(1985) , 10.1093/CARCIN/6.3.403
John B. Little, Sukdeb Mondal, Charles Heidelberger, Ann R. Kennedy, Enhancement of X-ray transformation by 12-O-tetradecanoyl-phorbol-13-acetate in a cloned line of C3H mouse embryo cells. Cancer Research. ,vol. 38, pp. 439- 443 ,(1978)
M. B. Kroeger-Koepke, R. M. Kovatch, C. J. Michejda, Carcinogenic Effects of Sequential Administration of Two Nitrosamines in Fischer 344 Rats Cancer Research. ,vol. 46, pp. 2252- 2256 ,(1986)
Arthur W. Bull, Lawrence J. Marnett, Elizabeth J. Dawe, Norman D. Nigro, Stimulation of deoxythymidine incorporation in the colon of rats treated intrarectally with bile acids and fats. Carcinogenesis. ,vol. 4, pp. 207- 210 ,(1983) , 10.1093/CARCIN/4.2.207
Charles Heidelberger, Aaron E Freeman, Roman J Pienta, Andrew Sivak, John S Bertram, Bruce C Casto, Virginia C Dunkel, Mary W Francis, Takeo Kakunaga, John B Little, Leonard M Schechtman, Cell transformation by chemical agents — A review and analysis of the literature Mutation Research/Reviews in Genetic Toxicology. ,vol. 114, pp. 283- 385 ,(1983) , 10.1016/0165-1110(83)90036-2
Hiroshi Yamasaki, Anne-Marie Aguelon-Pegouries, Taira Enomoto, Nicole Martel, Gerhard Furstenberger, Friedrich Marks, Comparative effects of a complete tumor promoter, TPA, and a second-stage tumor promoter, RPA, on intercellular communication, cell differentiation and cell transformation Carcinogenesis. ,vol. 6, pp. 1173- 1179 ,(1985) , 10.1093/CARCIN/6.8.1173